TNBIOTCGrain Mill ProductsFiscal year ends December 31
Tanke Biosciences Corp
Financials through Q3 FY2013, quarter ended Sep 30, 2013Last filing: 10-Q on Nov 14, 2013
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $399.72K
- P/E (TTM)
- –
- Dividend yield
- –
Tanke Biosciences Corp revenue by segment
By business segment
| Revenue | TTM Q3 13 | TTM Q2 13 | TTM Q1 13 | TTM Q4 12 | TTM Q3 12 | TTM Q2 12 | TTM Q1 12 | TTM Q4 11 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Organic Trace Mineral Additives [Member] | $18.74M | $22.88M | $25.08M | $24.59M | $23.45M | $19.74M | $17.16M | $18.86M | 81.6% | -20.1% |
| Functional Regulation Additives [Member] | $2.19M | $2.31M | $2.65M | $3.06M | $4.08M | $4.34M | $4.45M | $4.16M | 9.5% | -46.4% |
| Other [Member] | $1.21M | $1.04M | $614.43K | $623.33K | $755.95K | $549.36K | $548.17K | $531.91K | 5.3% | +60.5% |
| Herbal Medicinal Additives [Member] | $819.18K | $604.41K | $330.37K | $293.45K | $247.48K | $246.54K | $275.30K | $281.04K | 3.6% | +231.0% |
By product or service
By region
From the segment and revenue-disaggregation notes of Tanke Biosciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.